Products for Research Use Only
RegisterLogin

Gentiopicroside

CAT: 0804-HY-N0494-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N0494-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Gentiopicroside, a naturally occurring iridoid glycoside, inhibits P450 activity, with an IC50 and a Ki of 61 μM and 22.8 μM for CYP2A6; Gentiopicroside has anti-inflammatoryand antioxidative effects.
CAS Number
20831-76-9
Product Name Alternative
Gentiopicrin
UNSPSC
12352005
Hazard Statement
H302
Target
Cytochrome P450; HCV
Type
Natural Products
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Gentiopicroside.html
Purity
99.83
Solubility
DMSO : 250 mg/mL (ultrasonic) |H2O : ≥ 100 mg/mL
Smiles
C=C[C@@H]([C@@H]1O[C@]([C@@H]([C@@H](O)[C@@H]2O)O)([H])O[C@@H]2CO)C(C3=CO1)=CCOC3=O
Molecular Formula
C16H20O9
Molecular Weight
356.32
Precautions
H302
References & Citations
[1]Deng Y, et al. In vitro inhibition and induction of human liver cytochrome P450 enzymes by gentiopicroside: potent effect on CYP2A6. Drug Metab Pharmacokinet. 2013;28 (4) :339-44. Epub 2013 Feb 19.|[2]Yang Y, et al. Protective effect of gentiopicroside from Gentiana macrophylla Pall. in ethanol-induced gastric mucosal injury in mice. Phytother Res. 2018 Feb;32 (2) :259-266.|[3]Chen F, et al. Gentiopicroside inhibits RANKL-induced osteoclastogenesis by regulating NF-κB and JNK signaling pathways. Biomed Pharmacother. 2018 Apr;100:142-146.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
CYP2

Alternative Products

CatalogName
293582-01Gentiopicroside
A22172-5Gentiopicroside 5mg
A22172-50Gentiopicroside 50mg
A22172-10Gentiopicroside 10mg
A22172-100Gentiopicroside 100mg
371479Gentiopicroside discontinued

Popular Products